These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9988118)

  • 1. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
    Von Lubitz DK
    Eur J Pharmacol; 1999 Jan; 365(1):9-25. PubMed ID: 9988118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
    von Lubitz DK
    Eur J Pharmacol; 1999 Apr; 371(1):85-102. PubMed ID: 10355598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A3 receptor stimulation and cerebral ischemia.
    Von Lubitz DK; Lin RC; Popik P; Carter MF; Jacobson KA
    Eur J Pharmacol; 1994 Sep; 263(1-2):59-67. PubMed ID: 7821362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?
    von Lubitz DK; Ye W; McClellan J; Lin RC
    Ann N Y Acad Sci; 1999; 890():93-106. PubMed ID: 10668416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine receptors in cerebral ischemia.
    Melani A; Pugliese AM; Pedata F
    Int Rev Neurobiol; 2014; 119():309-48. PubMed ID: 25175971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist.
    Von Lubitz DK; Beenhakker M; Lin RC; Carter MF; Paul IA; Bischofberger N; Jacobson KA
    Eur J Pharmacol; 1996 Apr; 302(1-3):43-8. PubMed ID: 8790990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.
    Bischofberger N; Jacobson KA; von Lubitz DK
    Ann N Y Acad Sci; 1997 Oct; 825():23-9. PubMed ID: 9369972
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists.
    Jacobson KA; Xie R; Young L; Chang L; Liang BT
    J Biol Chem; 2000 Sep; 275(39):30272-9. PubMed ID: 10887176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroprotective mechanisms of adenosine action on CNS neurons].
    Zalewska-Kaszubska J
    Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine as a Key Mediator of Neuronal Survival in Cerebral Ischemic Injury.
    Khan H; Kaur P; Singh TG; Grewal AK; Sood S
    Neurochem Res; 2022 Dec; 47(12):3543-3555. PubMed ID: 36042141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of ischemia-evoked release of excitatory and inhibitory amino acids by adenosine A1 receptor agonist.
    Goda H; Ooboshi H; Nakane H; Ibayashi S; Sadoshima S; Fujishima M
    Eur J Pharmacol; 1998 Sep; 357(2-3):149-55. PubMed ID: 9797030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia.
    Carr CS; Hill RJ; Masamune H; Kennedy SP; Knight DR; Tracey WR; Yellon DM
    Cardiovasc Res; 1997 Oct; 36(1):52-9. PubMed ID: 9415272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke.
    Von Lubitz DK; Simpson KL; Lin RC
    Ann N Y Acad Sci; 2001 Jun; 939():85-96. PubMed ID: 11462807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine in the treatment of stroke: yes, maybe, or absolutely not?
    von Lubitz DK
    Expert Opin Investig Drugs; 2001 Apr; 10(4):619-32. PubMed ID: 11281813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.
    Von Lubitz DK; Lin RC; Bischofberger N; Beenhakker M; Boyd M; Lipartowska R; Jacobson KA
    Eur J Pharmacol; 1999 Mar; 369(3):313-7. PubMed ID: 10225368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia.
    Pedata F; Corsi C; Melani A; Bordoni F; Latini S
    Ann N Y Acad Sci; 2001 Jun; 939():74-84. PubMed ID: 11462806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement.
    Armstrong S; Ganote CE
    Cardiovasc Res; 1994 Jul; 28(7):1049-56. PubMed ID: 7525060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.
    Shryock JC; Belardinelli L
    Am J Cardiol; 1997 Jun; 79(12A):2-10. PubMed ID: 9223356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.